Digital marketing

Universe Pharmaceuticals INC announces strategic partnership with Lian-Ou Health to grow its digital marketing and sales on e-commerce platforms

Universe Pharmaceuticals INC announces strategic partnership with Lian-Ou Health to grow its digital marketing and sales on e-commerce platforms

Universe Pharmaceuticals INC

Ji’an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:UPC), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a strategic cooperation agreement (the “Agreement”) with Lian-Ou Health Pharmaceutical (Guangzhou) Co., Ltd. (“Lian-Ou Health”), a high-tech company focused on pharmaceuticals, technology, operations, sales and services, to develop the Company’s digital marketing and expand its sales channels across e-commerce.

Pursuant to the agreement, Lian-Ou Health will serve as the exclusive partner for the Company’s digital marketing efforts and authorized partner for the sale of the Company’s products on e-commerce platforms until December 31, 2024. Both parties have agreed to cooperate with each other in areas such as product promotion, product development and support, and customer services by taking advantage of each other’s resources and advantages. Both parties have also agreed to provide training to each other’s employees to further enhance their competitiveness.

The strategic alliance with Lian-Ou Health is one of the company’s approaches to staying competitive in the rapidly changing digital economy in China and addressing the challenges associated with the COVID-19 pandemic by exploring marketing solutions and digital sales. In addition, the Company is focusing on its current business lines and continuously innovating in the development of digital marketing and sales on e-commerce platforms, which is expected to provide the Company with a new growth opportunity in the face of the evolution of market.

Mr. Hanhui Li, Vice President of Lian-Ou Health, said, “As a practitioner of Direct-To-Consumer (“DTC”) pharmaceutical digital marketing and sales strategy, Lian-Ou Health has explored marketing strategies to adapt to changes. in the pharmaceutical market. Going forward, Lian-Ou Health will integrate digital capabilities and marketing resources for the company’s digital transformation and work together to build the company’s image as a long-standing company with well-known brands.

Mr. Baochang Liu, COO of Universe Pharmaceuticals INC, said, “Cooperating with Lian-Ou Health will increase the brand value of the company and is also an important step for the company towards the path of digital marketing. With Lian-Ou Health’s expertise, we will expand our digital marketing capabilities and further enhance our brand recognition.

Mr. Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, said, “The company has always been deeply committed to the traditional Chinese medicine market. We adhere to the production of high-quality products and strive to enhance the brand recognition of our product ‘Bai Nian Dan’ among middle-aged and elderly people. Recent changes in the macro environment and consumer preferences are pushing the Company to strengthen its brands through digital marketing and sales on e-commerce platforms. In the future, we believe that our strategic cooperation with Lian-Ou Health will help us achieve long-term sustainable development. »

On Lian-Ou Health Pharmaceutical (Guangzhou) Co., Ltd.

Lian-Ou Health is a high-tech enterprise focusing on medical treatment, technology, operation, sales and service. Lian-Ou Health provides core digital services for medical and healthcare professional customers, including digital marketing services, self-developed AI-assisted diagnosis and treatment system, SaaS system for operating the private domain traffic and a networked clinic SaaS system, Lian-Ou Health aims to help digital upgrading, content upgrading and upgrading members of the medical industry and the health. For more information, visit the website at

About Universe Pharmaceuticals INC

Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a pharmaceutical manufacturer and distributor in China. The Company specializes in the manufacture, marketing, sale and distribution of products derived from traditional Chinese medicine targeting the elderly with the aim of treating their physical conditions in the aging process and promoting their general well-being. The Company also distributes and sells biomedical drugs, medical devices, traditional Chinese medicine parts and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the Company’s products are sold to 30 provinces in China. For more information, visit the Company’s website at

Forward-looking statements

All statements other than statements of historical facts in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections regarding future events and financial trends that the Company believes could affect its financial condition, results of operations, business strategy and his financial needs. Investors can identify these forward-looking statements by words or phrases such as “may”, “will”, “expect”, “anticipate”, “aim”, “estimate”, “has intention to”, “plans”, “believes”, “potential”, “continues”, “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent events or circumstances, or changes in its expectations, except as required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will prove to be correct, and the Company cautions investors that actual results may differ materially from anticipated results and encourages investors to discuss other factors that could affect its future results in the Company’s registration statement and other filings with the SEC.

For more information please contact:

Ascent Investor Relations LLC
Tina Xiao
Phone: 917-609-0333
E-mail: [email protected]